Structure and lipophilicity--the keys to understanding the function of pyruvate derivatives for ischemia/reperfusion?
Structure and lipophilicity--the keys to understanding the function of pyruvate derivatives for ischemia/reperfusion?
复制标题
结构和亲脂性——理解丙酮酸衍生物缺血/再灌注功能的关键?
DOI:
10.1016/j.jss.2009.12.007
复制
发表时间:
2010
期刊:
影响因子:
--
通讯作者:
Abarbanell,AaronM
中科院分区:
文献类型:
--
作者:
Abarbanell,AaronM
Pyruvate and pyruvate derivatives are a large focus of basic science research due to their ability to decrease inflammation and organ dysfunction in response to injury. In animal models sodium pyruvate (NaPyr) or the anion form pyruvate are known to attenuate myocardial, renal and hepatic organ dysfunction after injury [1–3]. Pyruvate is also associated with improved outcomes after severe shock [4, 5]. However, NaPyr is not stable in aqueous solutions and undergoes hydration and condensation reactions that may limit its effectiveness [6].In an attempt to solve this problem, Dr. Fink’s group studied the effects of ethyl pryuvate (EP), a pyruvate derivative, and reported that the effects of EP were superior to pyruvate in a model of intestinal ischemia/reperfusion (I/R)[7]. This group subsequently reported the protective role of EP in models of sepsis and inflammation [8–10]. Now in this manuscript by Cruz and colleagues, the group investigated the underlying mechanisms that might differentiate the protective role of EP and other pyruvate derivatives from pyruvate.